Dr. Éric Poirier is a surgeon-oncologist at the CHU de Québec-Laval University. He is also a clinical researcher at the Research Center of the CHU de Québec-Laval University, and clinical professor at the Faculty of Medicine of Laval University. Dr. Poirier is part of the research group of the Centre des Maladies du Sein of CHU de Québec-Laval University.
Using structured breast cancer data
The research team of the Centre des Maladies du Sein has a comprehensive database of all cancers diagnosed since 1974; more than 12,000 patients are listed. A database of biopsy data from 1999 is also available; data on more than 34,000 biopsies are listed. These databases allow quality publications that modify the management and management of cancers and benign breast diseases.
Offer innovative treatments
The Centre des Maladies du Sein of CHU de Québec-Laval University research group is one of the largest in Canada, offering innovative treatments for breast cancer. More than 50 clinical trials are active at all times and are offered to patients who consult at the clinic or are referred by clinics/hospitals in the area. These clinical trials provide access to innovative experimental medications and develop the expertise of our world-renowned oncologists.
Support the quality of life
The Centre des Maladies du Sein of CHU de Québec-Laval University research group is a pioneer in quality of life studies in breast cancer, from total mastectomy to partial mastectomy, to the use of the cooling cap to counteract hair loss, promoting physical activity to improve survivorship, including optimal preservation of the axillary lymph nodes. The research group is at the forefront of studies promoting quality of life despite the adverse effects of the disease on an individual’s life.
1050, chemin Sainte-Foy
Centre des maladies du sein Deschênes-Fabia
Canada G1S 4L8
Data not available
Is there an Upgrading to Malignancy at Surgery of Mucocele-Like Lesions Diagnosed on Percutaneous Breast Biopsy?Journal Article
Breast J, 22 (2), 2016.
Metastatic pattern of invasive lobular carcinoma of the breast-Emphasis on gastric metastasesJournal Article
J Surg Oncol, 114 (5), 2016.
Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patientsJournal Article
Ann Pharmacother, 48 (4), 2014.
Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsyJournal Article
Anticancer Res, 34 (3), 2014.
Management of exclusively dopamine-secreting abdominal pheochromocytomasJournal Article
J Am Coll Surg, 216 (2), 2013.
- Enabling circularity in energy systems: Design and development of an energy digital twin, from 2023-04-01 to 2024-04-30
- NSABP Breast Cancer Treatment Protocols, from 1997-02-01 to 2025-12-25